Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is attempt to establish optimum drive pressure of high frequency jet ventilation during rigid bronchoscopy to ensure good aeration of the lungs examined by electrical impedance tomography.

Clinical Trial Description

The study was performed in the Department of Anaesthesiology and Intensive Therapy in Zabrze.

After application of eligibility criteria 30 patients were enrolled in a prospective, observational study. Each patient received an information about the study and the consent form to carry out the measurement procedures was obtained. The data about sex, age, weight, height, comorbidities, BMI were collected.

Patients were given premedication, midazolam (Sopodorm, ICN Polfa Rzeszow, Poland; doses: weight 80kg - 7.5 mg; weight 80-100kg - 15mg) on hour before projected surgery.

Upon arrival to the operating room patient's basic monitoring was provided: ECG (3 leads), heart rate, noninvasive measurement of blood pressure (NIBP), and pulse oximetry. At the same time, a belt with electrodes was put on a patient to monitor impedance tomography, then an automatical record of the basic parameters of regional lung ventilation was turned on.

The medications used for induction of anesthesia: fentanyl (Fentanyl WZF, Polfa Warsaw, Poland) at a dose of 2 g /kg bw i.v., propofol (Diprivan, AstraZeneca, PolskaPlofed Polpharma Poland) at a dose of 2 mg / kg bw, i.v. and to carry out an intubation - cis-atracurium (Nimbex, GlaxoSmithKine, UK) at dose of 0.15 mg /kg bw i.v. During rigid bronchoscopy maintenance of general anesthesia was achieved through the supply of intravenous propofol at a dose of 10 - 6 mg/kg bw/h.The high frequency jet ventilation (HFJV) was performed with proper respirator (Universal Jet Ventilator Monsoon DeLuxe ACUTRONIC Switzerland), using following ventilation parameters: f = 160-200 breaths / min, FiO2 (fraction of inspired oxygen) = 1, the DP (drive pressure) = 1.5-2.5 Atm. Simultaneously, patients were monitored using a PulmoVista 500 Dräger device and aeration of the lungs examined by electrical impedance tomography were observed in a monitor.

During anesthesia, patients received hydration in the form of a 0.9% solution of Ringer's lactate at 4 ml/kg bw/h. In the event of bradycardia atropine (Atropine sulfuricum, Polfa Warsaw, Poland) at dose of 0.5 mg iv was given, in the event of a decrease in mean arterial pressure below 70 mmHg or 25% compared to the output pressure, ephedrine (Ephedrinum Hydrochloricum WZF, Polfa Warsaw, Poland) in fractionated doses of 5 mg iv (Max 25 mg) was given and in the case of the ineffectiveness of the proceedings dopamine infusion (Dopaminum Hydrochloricum WZF 4%, Polfa Warsaw, Poland) in the syringe pump titrated to maintain a mean arterial pressure above 70 mmHg.

Recovery from anesthesia took place at the recovery room after the removal of the anesthetics and muscle relaxants. If necessary, reverse the action of muscle relaxants was announced neostigmine (Polstygminum, Teva Pharmaceuticals Poland, Poland) at a dose of 0.5 - 2.5 mg i.v.

During anesthesia following parameters were monitored: ECG (3 leads), heart rate, noninvasive blood pressure (NIBP) every 3 minutes and arterial oxygen saturation measured by pulse oximetry. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

NCT number NCT02997072
Study type Observational
Source Silesian University of Medicine
Status Completed
Phase N/A
Start date July 2014
Completion date December 2016

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Completed NCT01826994 - Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome N/A
Active, not recruiting NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Not yet recruiting NCT04351815 - Short-term Prehabilitation Program : Interest of on Resumption of Function at 2 Months N/A
Recruiting NCT04498208 - Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery N/A
Completed NCT03768193 - Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery N/A
Completed NCT03307551 - Evaluation of Automated Propofol Delivery in Patients Undergoing Thoracic Surgery Phase 4
Completed NCT03286400 - Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL
Not yet recruiting NCT04630496 - Geriatric Thoracic Surgery Ambulation Challenge N/A
Recruiting NCT02971917 - A Clinical Study of TRUVIEW ARTâ„¢(Advanced Reconstruction Tech)to Improve Image Quality on Chest Radiograph N/A
Completed NCT02133235 - The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial Blocker N/A
Completed NCT03922516 - Accuracy of Ultra-Low-Dose-CT of the Chest Compared to Plain Film in an Unfiltered Emergency Department Patient Cohort N/A
Completed NCT03080831 - TOnicity of Perioperative Maintenance SoluTions Phase 4
Terminated NCT02391896 - Design and Evaluation of Mobile X-ray for Rapid and Accurate Diagnosis of Thoracic Disease N/A
Completed NCT03144479 - New Technique to Assess Correct Positioning of the Right-sided Double Lumen Tube N/A
Recruiting NCT04309630 - Comparison of Continuous Erector Spina Plane Block With Intercostal Block in Acute and Chronic Pain Control After Thoracotomy N/A
Recruiting NCT04118660 - Thoracic Specimen Registry
Completed NCT02799251 - Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections
Completed NCT02190201 - Comparison of McGrath and Macintosh Laryngoscope for DLT Intubation Phase 4
Completed NCT00719784 - Vibration Response Imaging in the Diagnosis of Pulmonary Disease N/A